As the Kansas City Chiefs are gearing up to become the NFL's first-ever three-peat Super Bowl champions, Eli Manning had a three-peat of his own. For the third consecutive year coaching the NFC ...

During a recent interview on "Up & Adams," Giants legend Eli Manning was asked which quarterback prospect he was excited to scout first. While Manning did not list one quarterback, he did mention ...

With its offering of tirzepatide (branded as Mounjaro and Zepbound), Eli Lilly and Co. (NYSE: LLY) was another key pharma player in this new type of treatment for diabetes and obesity.

Not long after reporting phase 2 data for one of its obesity candidates that appeared to put it on par with Eli Lilly’s Zepbound, Kailera Therapeutics is preparing for an eventual market launch ...

Citi analyst Geoff Meacham maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) today. The company’s shares closed last Friday at $785.41. Meacham covers the Healthcare sector ...

On an investment spree with billions of dollars’ worth of projects ongoing globally, Indianapolis-based Eli Lilly and Company chose Kenosha County for its latest – and one of its largest ...

If Eli Lilly has its way, this may be the future of obesity care. Eli Lilly makes some of the most powerful weight-loss drugs in the world. The company has pivoted dramatically over the past ...

Sundance: Chloé Robichaud's comedy remake, both fun and retrograde, would make Neil Simon proud. So, despite its very modern exploration of female desire, there’s something creaky about “Two ...

To address this, American pharmaceutical giant Eli Lilly is focusing on weight loss medications like Mounjaro (tirzepatide), which has proven effective in managing both obesity and type-2 diabetes.